|
WO2020186089A1
|
|
Result determination in an immunoassay by measuring kinetic slopes
|
|
US2020292543A1
|
|
Compositions, kits, and methods for detecting autoantibodies
|
|
WO2020150403A1
|
|
System and methods for remote assessment of a sample assay for disease diagnostics
|
|
US2020116720A1
|
|
Extraction reagent for use in an assay for detection of group a streptococcus
|
|
US2020062832A1
|
|
DbpA ANTIBODIES AND USES THEREOF
|
|
CN111788314A
|
|
Phage-based detection method for antimicrobial susceptibility testing and bacterial species validation
|
|
EP3580566A1
|
|
Lateral flow assay with substrate having channels for controlled fluid flow
|
|
CN111601897A
|
|
Phage-mediated immunoassay and method for determining susceptibility of bacteria to antibiotics or beneficial agents
|
|
EP3541515A1
|
|
Device for whole blood separation
|
|
US2018136246A1
|
|
Device, instrument, and method for inductive heating of a sample for analyte detection
|
|
US2017292964A1
|
|
Processing reagent and use thereof in assays for detection of analytes associated with a binding protein
|
|
US2017059566A1
|
|
Immunoassay test device with two fluid flow paths for detection and differentiation of two or more analytes
|
|
US2017177724A1
|
|
System for collecting and displaying diagnostics from diagnostic instruments
|
|
EP3077798A1
|
|
Method for reducing analyzer variability using a normalization target
|
|
WO2015061598A1
|
|
Systems and methods for whole blood assays
|
|
WO2014164563A1
|
|
Pcr assays and reagents for molecular detection of infectious agents
|
|
US2014255275A1
|
|
Dual chamber liquid packaging system
|
|
US2014170770A1
|
|
Methods of use for an immunoassay detecting fragment Ba
|
|
US2014120552A1
|
|
Sensitive and rapid methods of using chimeric receptors to identify autoimmune disease and assess disease severity
|
|
US2015050671A1
|
|
Method for species-independent measurement of complement activation in animals
|
